Hisamitsu America engages in the research and development of pain relieving patches and pharmaceutical products based on the transdermal therapeutic systems. Ito offers transdermal drug delivery systems (TDDS) products, including poultices, plasters, and ointments that are used for maintaining a steady drug concentration in the bloodstream; controlling dosage over a specific period of time; the avoidance of the first-pass effect through the liver; and reducing harmful effects to the digestive system. The company’s TDDS are also used for patients having difficulty swallowing; children; the elderly and others; treatment of skin diseases and muscle pain; and treatment of various diseases and conditions, such as angina pectoris, asthma, and hypertension. Its products include SALONPAS PAIN RELIEF PATCH, an over the counter (OTC) topical pain relief patch for the temporary relief of mild to moderate muscles and joints aches and pains associated with arthritis, strains, and backache. In addition, the company offers SALONPAS for stiffness and tightness in the neck and shoulders; SALONPAS LARGE, a larger patch for wider area aches and pains; SALONPAS HOT patches to the back and to the lower back; SALONPAS GEL for aching muscles, sprains, and bruises; and SALONSIP AQUA-PATCH, a stretchable self-adhesive gel patch. Its products are sold through a network of resellers in Asia and around the world. The company was founded in 1987 and is based in Torrance, California.
History of SALONPAS®
In the century-and-a-half since our founding, Hisamitsu has pioneered the development of patches and other topical treatments to relieve everyday aches and pains. Our SALONPAS® product line gained early acceptance in Asia and now sells in 50 countries around the world.
Although our products now enjoy international recognition, we started out as a small, family owned business in Japan. Hisamitsu Pharmaceutical was founded in the mid-19th century under the name of Komatsuya. The company went on to create a large variety of health-related products. Our company has always prided itself on its ability to create new consumer products based on Hisamitsu’s comprehensive research, development, manufacturing, and sales capabilities.
SALONPAS® brand patches were first introduced in 1934, and their outright efficacy propelled our company to the position of market leadership that we currently hold today. SALONPAS® was developed through the application of Asahi Mankinko, the prototype therapeutic patch we introduced back in 1903. The original product gained quick acceptance and was considered cutting edge technology in its day. Thanks to sustained research and input from everyday users, our products continue to evolve. Moreover, our company has expanded the culture and use of patch treatment. Hisamitsu continues to develop and refine therapeutic patches that are safe and easy to use.
We believe the fulfillment of our mission is nothing less than an obligation to the global community. It is with that in mind that we work to improve our products and promote new means for people everywhere to apply the many benefits of topical care. Hisamitsu’s goal has always been to advance the benefits of external analgesic treatments, especially their pain-relieving effects and the feeling of invigoration they offer. Nowhere is this objective better expressed than in our corporate maxim, “Salonpathy”. This word was derived from SALONPAS®, one of our key products. Under the banner of Salonpathy, we are actively promoting better health for people around the world, offering a range of pain relieving patches and pharmaceutical products. As the 21st century begins, we are responding to basic needs that unite people everywhere. Good health, freedom from pain and a lifestyle rich in vitality, is the foundation for all we do at Hisamitsu. Our business strategy is designed to develop new medical products and drugs commensurate with our core competencies in external analgesic. This is our mission, to make topical care available for all who seek it-anytime, anywhere.
Research & Development
The future of pharmaceutical products is one of unprecedented possibilities. Hisamitsu’s efforts in research and development are focused on external analgesic products. The poultices, plasters, and ointments applied to the skin have been used for many generations. There are good reasons that this tried and true technology of administering drugs through the surface of the skin for delivery throughout the body is enjoying modern day popularity.
Maintaining a steady drug concentration in the bloodstream
Controlling dosage over a specific period of time
Avoidance of the first-pass effect through the liver
Reducing any harmful effects to the digestive system.